Related references
Note: Only part of the references are listed.The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery
Filip Machaj et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis
Shyi-Jou Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Optimising low-dose methotrexate for rheumatoid arthritis-A review
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases
Marialbert Acosta-Herrera et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients
John C. Taylor et al.
PHARMACOGENOMICS JOURNAL (2018)
Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis
Rosario Lopez-Rodriguez et al.
SCIENTIFIC REPORTS (2018)
Diagnosis and Management of Rheumatoid Arthritis A Review
Daniel Aletaha et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Novel treatment strategies in rheumatoid arthritis
Gerd R. Burmester et al.
LANCET (2017)
Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis
Qi Qiu et al.
MEDICINE (2017)
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study
Jeffrey A. Sparks et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Qi Qiu et al.
SCIENTIFIC REPORTS (2017)
Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches
Panonnummal Rajitha et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
HLA-A 31:01 is not associated with the development of methotrexate pneumonitis in the UK population: results from a genome-wide association study
James Bluett et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy
Maciej Tarnowski et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis A meta-analysis
Y. H. Lee et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2016)
The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis
XiaoBing Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story
Anand N. Malaviya
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Philip M. Brown et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome
Aurea Lima et al.
PHARMACOGENOMICS (2016)
Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis
Young Ho Lee et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis
Jerzy Swierkot et al.
JOINT BONE SPINE (2015)
Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis
Gwan Gyu Song et al.
CLINICAL RHEUMATOLOGY (2014)
Molecular Basis for Pharmacokinetics and Pharmacodynamics of Methotrexate in Rheumatoid Arthritis Therapy
Katsuhisa Inoue et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?
Sunitha Kodidela et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation
Sabyasachi Senapati et al.
PHARMACOGENETICS AND GENOMICS (2014)
Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis
Ling Ling Zhang et al.
PHARMACOGENETICS AND GENOMICS (2014)
SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients
Aurea Lima et al.
PHARMACOGENOMICS (2014)
Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update
Hong Zhu et al.
PHARMACOGENOMICS (2014)
Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases
J. Cobb et al.
PHARMACOGENOMICS JOURNAL (2014)
Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
Aurea Lima et al.
PLOS ONE (2014)
SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients
Aurea Lima et al.
TOXICOLOGICAL SCIENCES (2014)
RFC1 80G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies
Tabitha N. Kung et al.
ARTHRITIS & RHEUMATOLOGY (2014)
HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?
Hiroshi Furukawa et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Genome-wide study of methotrexate clearance replicates SLCO1B1
Laura B. Ramsey et al.
BLOOD (2013)
Role of Methotrexate Polyglutamation and Reduced Folate Carrier 1 (RFC1) Gene Polymorphisms in Clinical Assessment Indexes
Yukie Ando et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
A Single Nucleotide Polymorphism of Reduced Folate Carrier 1 Predicts Methotrexate Efficacy in Japanese Patients with Rheumatoid Arthritis
Hideki Hayashi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Pharmacogenetics and pharmacogenomics in rheumatology
Zoltan Szekanecz et al.
IMMUNOLOGIC RESEARCH (2013)
The advantages and limitations of trait analysis with GWAS: a review
Arthur Korte et al.
PLANT METHODS (2013)
A2A Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats
Fabrizio Vincenzi et al.
PLOS ONE (2013)
Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate
Cristina Lucia Davila-Fajardo et al.
PHARMACOGENOMICS (2013)
Methotrexate pharmacogenetics in rheumatoid arthritis: a status report
Fardina Malik et al.
PHARMACOGENOMICS (2013)
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
S. A. Owen et al.
PHARMACOGENOMICS JOURNAL (2013)
Mapping cis- and trans-regulatory effects across multiple tissues in twins
Elin Grundberg et al.
NATURE GENETICS (2012)
Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis
Kalliopi P. Spyridopoulou et al.
PHARMACOGENETICS AND GENOMICS (2012)
Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients
Petra Bohanec Grabar et al.
PHARMACOGENOMICS (2012)
Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis
Lin Yang et al.
TUMOR BIOLOGY (2012)
Spontaneous Lung Dysfunction and Fibrosis in Mice Lacking Connexin 40 and Endothelial Cell Connexin 43
Michael Koval et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis
Junpei Teramachi et al.
LABORATORY INVESTIGATION (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases
Lisa K. Stamp et al.
PHARMACOGENOMICS (2011)
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study
Diego Kyburz et al.
RHEUMATOLOGY (2011)
Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their Application
Rita M. Cantor et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Associations between the C677T and A1298C Polymorphisms of MTHFR and the Efficacy and Toxicity of Methotrexate in Rheumatoid Arthritis A Meta-Analysis
Young Ho Lee et al.
CLINICAL DRUG INVESTIGATION (2010)
Pharmacogenetics in Treatment of Rheumatoid Arthritis
W. M. Kooloos et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Guillermo Gervasini
CURRENT DRUG METABOLISM (2009)
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival
Alessia Ongaro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis
H. Hayashi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2009)
Metaanalysis of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms Affecting Methotrexate Toxicity
Mark C. Fisher et al.
JOURNAL OF RHEUMATOLOGY (2009)
Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate
Yvonne C. Lee et al.
RHEUMATOLOGY (2009)
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Marc Feldmann et al.
IMMUNOLOGICAL REVIEWS (2008)
Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
L. Huang et al.
LEUKEMIA (2008)
Reduced folate carrier-1 80G > A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis
M. Drozdzik et al.
PHARMACOGENOMICS JOURNAL (2007)
677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis
Mateusz Kurzawski et al.
PHARMACOGENOMICS (2007)
The anti-inflammatory effect of A3 adenosine receptor agonists:: a novel targeted therapy for rheumatoid arthritis
Sara Bar-Yehuda et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis
Emanuela Campalani et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis
Axel Finckh et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis
Thierry Dervieux et al.
ARTHRITIS AND RHEUMATISM (2006)
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis
Judith A. M. Wessels et al.
ARTHRITIS AND RHEUMATISM (2006)
Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes
JAM Wessels et al.
ARTHRITIS AND RHEUMATISM (2006)
Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines
S Herman et al.
INFLAMMATION RESEARCH (2005)
The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules
A Johnston et al.
CLINICAL IMMUNOLOGY (2005)
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review
SL Whittle et al.
RHEUMATOLOGY (2004)
Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin
H Sigmundsdottir et al.
EXPERIMENTAL DERMATOLOGY (2004)
Gap junctions and the connexin protein family
G Söhl et al.
CARDIOVASCULAR RESEARCH (2004)
The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species
DC Phillips et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The epidemiology of rheumatoid arthritis
SE Gabriel
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2001)
Share Paper
